The May 28, 2019 edition of Chronicle on WCVB 5 featured our incredible Memory and Aging Program participants and a look at how we’re working together to win the battle against Alzheimer’s by finding effective treatments and prevention. See their inspiring stories and why there’s hope on the horizon in the clips below.
If you’re 40+ with normal memory or mild memory loss, you can help us in this fight. Here’s how: butler.org/ALZregistry
Chronicle’s Anthony Everett takes us inside Butler Hospital, one of the top Alzheimer’s research centers in the world.
A genetic test revealed that Dave Kalberer carried the markers for Alzheimer’s. He is now enrolled in a clinical trial through the Memory and Aging Program at Butler Hospital.
Anthony Everett reports on a billion-dollar effort underway to find breakthrough treatments in the next decade.
Alzheimer’s disease is a relentless force, stealing patients’ dignity and emotionally exhausting their families, caregivers and friends. How do we fight back?
Watch this Alzheimer’s educational video to learn about prevention, symptoms, treatment, resources and research from a panel of Rhode Island experts.
What to expect and what to do during each stage of Alzheimer’s to ensure the best possible quality of life and peace of mind.
Providence College senior Gregory Pappas was looking for a good internship. What he found was the start of his life’s work, at a leading center of Alzheimer’s research.
URI, BayCare and Butler Hospital to test retinal scanning for early detection of Alzheimer’s disease
Study seeks 330 volunteers for clinical trials.
On New Year's day GoLocalProv announced that it had selected Stephen Salloway, M.D. as its Man of the Year for 2019. Dr. Salloway, a world leader in Alzheimer's research, is director of Neurology and the Memory and Aging Program at Butler Hospital and Martin M. Zucker...
Major Alzheimer’s Association grant to enable researchers to test a drug that could slow the progression of Alzheimer’s disease.
With a special combination of compassionate care and scientific inquiry, she’s part of the front-line fight to end Alzheimer’s.
Ray and Elaine Theriault have embarked on many journeys in their 50+ years together. Now they’re on a new quest: to help end Alzheimer’s.
Drug Studied at Butler Hospital’s Memory and Aging Program May Become First New Treatment for Alzheimer’s in 16 Years
Aducanumab maker Biogen seeking FDA review in early 2020; if approved, it will become the first drug to remove amyloid protein from the brain and slow the progression of Alzheimer’s disease (AD).